SLE Treatment
Dec 23, 2024
7 Late-Stage SLE Drugs Expected to Enter Therapeutic Domain
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can affect multiple parts of the body. In 2023, it was estimated that around 500,000 individuals in the United States were living with SLE, as per DelveInsight analysis. The prevalence is significantly higher in females, who account for over ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
